| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
|
Özkan, A.
|
|
|
212 |
C |
p.
|
artikel
|
| 2 |
A new proposal of simplified classification of non-small cell lung cancer oligometastases for easy applicability through systematic literature analysis and meta-analysis validation
|
Kang, Hanseung
|
|
|
212 |
C |
p.
|
artikel
|
| 3 |
A novel computational pathology approach for identifying gene signatures prognostic of disease-free survival for papillary thyroid carcinomas
|
Monabbati, Shayan
|
|
|
212 |
C |
p.
|
artikel
|
| 4 |
Comparing supplemental indications for cancer drugs approved in the US and EU
|
Stoelinga, Jelle
|
|
|
212 |
C |
p.
|
artikel
|
| 5 |
Dose optimization of sotorasib: Has the burden of proof for the labeled dose been met?
|
Popat, Sanjay
|
|
|
212 |
C |
p.
|
artikel
|
| 6 |
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
|
Margalit, Ofer
|
|
|
212 |
C |
p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
212 |
C |
p.
|
artikel
|
| 8 |
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysis
|
Smabers, Lidwien P.
|
|
|
212 |
C |
p.
|
artikel
|
| 9 |
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
|
Meng, Xiangrui
|
|
|
212 |
C |
p.
|
artikel
|
| 10 |
Extracorporeal photopheresis vs. systemic immunosuppression for immune-related adverse events: Interim analysis of a prospective two-arm study
|
Ertl, C.
|
|
|
212 |
C |
p.
|
artikel
|
| 11 |
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 – Seasonal variation and association with outcome
|
Jurlander, Rebecca Schou
|
|
|
212 |
C |
p.
|
artikel
|
| 12 |
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs
|
van der Weijst, Lotte
|
|
|
212 |
C |
p.
|
artikel
|
| 13 |
Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancer
|
Benjamin, David J.
|
|
|
212 |
C |
p.
|
artikel
|
| 14 |
Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire
|
Oort, Q.
|
|
|
212 |
C |
p.
|
artikel
|
| 15 |
Letter of response re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
|
Zaun, Gregor
|
|
|
212 |
C |
p.
|
artikel
|
| 16 |
Letter Re: PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
|
Yu, Zhuoyang
|
|
|
212 |
C |
p.
|
artikel
|
| 17 |
Letter Re: Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
|
Zhu, Hao
|
|
|
212 |
C |
p.
|
artikel
|
| 18 |
Lung cancer volume doubling time by computed tomography: A systematic review and meta-analysis
|
Jiang, Beibei
|
|
|
212 |
C |
p.
|
artikel
|
| 19 |
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
|
Woodford, Rachel
|
|
|
212 |
C |
p.
|
artikel
|
| 20 |
Nivolumab plus ipilimumab with chemotherapy for non–small cell lung cancer with untreated brain metastases: A multicenter single-arm phase 2 trial (NIke, LOGiK 2004)
|
Tsuchiya-Kawano, Yuko
|
|
|
212 |
C |
p.
|
artikel
|
| 21 |
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study
|
M’Baloula, Jeannie
|
|
|
212 |
C |
p.
|
artikel
|
| 22 |
Onco-functional outcome after resection for eloquent glioblastoma (OFO): A propensity-score matched analysis of an international, multicentre, cohort study
|
Gerritsen, Jasper Kees Wim
|
|
|
212 |
C |
p.
|
artikel
|
| 23 |
Patient-reported outcomes in patients with metastatic non-squamous non-small cell lung cancer from the randomized Phase II PERLA trial comparing first-line chemotherapy plus dostarlimab or pembrolizumab
|
Reck, Martin
|
|
|
212 |
C |
p.
|
artikel
|
| 24 |
Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study
|
Zhou, Qing
|
|
|
212 |
C |
p.
|
artikel
|
| 25 |
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group
|
Elsayad, Khaled
|
|
|
212 |
C |
p.
|
artikel
|
| 26 |
Response to the Letter re: Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
|
Leonetti, Alessandro
|
|
|
212 |
C |
p.
|
artikel
|
| 27 |
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group
|
Toss, Angela
|
|
|
212 |
C |
p.
|
artikel
|
| 28 |
Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mm
|
Wenzel, Hans H.B.
|
|
|
212 |
C |
p.
|
artikel
|
| 29 |
Short- and long-term immunosuppressive effects of melanoma influence the prognostic value of the sentinel lymph node status
|
DeTemple, Viola K.
|
|
|
212 |
C |
p.
|
artikel
|
| 30 |
Temporal changes in survival among adult patients with acute lymphoblastic leukaemia diagnosed in the period 1998-2020 – A Danish nationwide population-based cohort study
|
Kristensen, Daniel Tuyet
|
|
|
212 |
C |
p.
|
artikel
|
| 31 |
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
|
Singer, Susanne
|
|
|
212 |
C |
p.
|
artikel
|
| 32 |
The tumor immune microenvironment of SCLC is not associated with its molecular subtypes
|
Velut, Yoan
|
|
|
212 |
C |
p.
|
artikel
|
Tijdschrift beschrijving